Skip to main content

Table 2 Major adverse reactions occurred during sedation

From: Safety and effcacy of remimazolam tosilate for sedation during combined spinal-epidural anesthesia for orthopedic procedures: a randomized controlled trial

 

Remimazolam(n = 40)

Dexmedetomidine(n = 40)

P-value

Total

40

40

 

Normal events

29(72.50%)

16(40.00%)

 

Adverse events

11(27.50%)

24(60.00%)

0.003

Transient hypotension

6(15.00%)

4(10.00%)

 

Desaturation

2(5.00%)

1(2.50%)

 

Bradycardia

3(7.50%)

21(52.50%)

 

Lethargy

1(2.50%)

7(17.50%)

 
  1. Data are presented as n (%)